Article info

Download PDFPDF

Letter
Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy

Authors

  1. Correspondence to Dr Jeffrey A Sparks; jsparks{at}bwh.harvard.edu
View Full Text

Citation

Vanni KM, Patel NJ, DiIorio M, et al
Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy

Publication history

  • Accepted November 12, 2021
  • First published February 2, 2022.
Online issue publication 
June 08, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.